Source: FinTech InShorts

CODA: Coda Biotherapeutics: Raises $28M In Financing -

Coda Biotherapeutics Raises $28M in Financing Coda Biotherapeutics, a San Francisco CA-based preclinical-stage biopharmaceutical company, raised $28M in

Read full article »

CODA's Competitors | CODA's News | CODA's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

President & CEO

Michael Narachi

CEO Approval Rating

90/100

CODA is a California-based biopharmaceutical company that develops and commercializes chemogenetic therapies for the treatment of neurological diseases.